Matches in Nanopublications for { ?s ?p "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP588094.RA-d30ywZ9o8Nt871Vah8iDZnlEZ71E8PzL7wBGUd5t6A130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588094.RA-d30ywZ9o8Nt871Vah8iDZnlEZ71E8PzL7wBGUd5t6A130_provenance.
- NP988022.RABYCmpR4DeIcjEtbEpNtC6VcGNjtb9Vm6kOCHeJSweGY130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988022.RABYCmpR4DeIcjEtbEpNtC6VcGNjtb9Vm6kOCHeJSweGY130_provenance.
- NP971324.RAVl0PuLPQb8byWVe0Dp84KTCzHq-FJgT35cEm7wzY4BQ130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971324.RAVl0PuLPQb8byWVe0Dp84KTCzHq-FJgT35cEm7wzY4BQ130_provenance.
- NP587481.RA_XwpaDkk_7KD2aLhDqsVXLhP8hqXBtdqNcZFOAUeLxQ130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587481.RA_XwpaDkk_7KD2aLhDqsVXLhP8hqXBtdqNcZFOAUeLxQ130_provenance.
- assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP988100.RAKv090AsMlCOk9fDIGKHAXJHAMory-v0kvWfB_1V2q7c130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988100.RAKv090AsMlCOk9fDIGKHAXJHAMory-v0kvWfB_1V2q7c130_provenance.
- NP587483.RAHlH9ByB4_ToG_oYSn0TtaUczqn_JSHRX3HccCc1eoww130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587483.RAHlH9ByB4_ToG_oYSn0TtaUczqn_JSHRX3HccCc1eoww130_provenance.
- assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP971405.RAjQlMUwCriBJ_21ag6epwF6PrsoiWlOKN5cPvv988TP8130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971405.RAjQlMUwCriBJ_21ag6epwF6PrsoiWlOKN5cPvv988TP8130_provenance.
- NP587479.RAlo53X4d8v8DkMOmmJQzmbw_nFAL4sfyCPH9ULy1GtY0130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587479.RAlo53X4d8v8DkMOmmJQzmbw_nFAL4sfyCPH9ULy1GtY0130_provenance.
- NP587480.RAnyZgSCdgMhW6YA_Hroe8wrni1l7AD4AlX8GPOwbDg50130_assertion description "[Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587480.RAnyZgSCdgMhW6YA_Hroe8wrni1l7AD4AlX8GPOwbDg50130_provenance.